Skip to main content

Table 5 Treatment modality by primary diagnosis

From: Late somatic sequelae after treatment of childhood cancer in Slovenia

Treatment
Primary diagnosis S RT CHT S_RT S_CHT RT_CHT S_RT_CHT
Leukemia 0.6% 1.1% 27.0% 0.6% 0.0% 70.1% 0.6%
NHL 2.3% 3.4% 25.3% 3.4% 16.1% 41.4% 8.0%
Neuroblastoma 37.5% 4.2% 0.0% 8.3% 25.0% 4.2% 20.8%
Other malignant neoplasms 40.0% 2.9% 2.9% 20.0% 25.7% 0.0% 8.6%
Rhabdomyosarcoma 2.9% 0.0% 0.0% 0.0% 20.6% 29.4% 47.1%
HD 0.0% 5.7% 4.1% 8.9% 1.6% 59.3% 20.3%
CNS 31.9% 3.5% 0.0% 35.4% 2.1% 2.8% 24.3%
Soft-tissue sarcomas 24.6% 0.0% 0.0% 10.8% 50.8% 1.5% 12.3%
Malignant bone tumors 3.9% 0.0% 0.0% 7.8% 60.8% 13.7% 13.7%
Other carcinomas 60.0% 2.9% 0.0% 18.6% 5.7% 4.3% 8.6%
Renal tumors 2.2% 0.0% 0.0% 11.1% 40.0% 0.0% 46.7%
  1. The influence of the primary diagnosis on the treatment modality.